Clinical trials
Phase 3 Essential Hypertension trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
119 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 8 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 12 |
| 2012 | 8 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 11 |
| 2023 | 4 |
| 2024 | 11 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 102 |
| Unknown status | 11 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 12 |
| Boryung Pharmaceutical Co., Ltd | 10 |
| Novartis Pharmaceuticals | 8 |
| Chong Kun Dang Pharmaceutical | 7 |
| Daiichi Sankyo | 7 |
| Novartis | 7 |
| Addpharma Inc. | 5 |
| Sankyo Pharma Gmbh | 5 |
| Bayer | 4 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 119 |
| Hypertension | 48 |
| Cardiovascular Diseases | 9 |
| Vascular Diseases | 5 |
| Dyslipidemias | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypercholesterolemia | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 76 to 100 of 119. Each trial links to its page on Pharma Observatory.
19 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.